Farmacogenómica del Cáncer ; Pharmacogenomic of cancer
Gedelcan
Centro de Investigaciones Biológicas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigaciones Biológicas (17)
2022
2021
-
Generation of a soluble form of human endoglin fused to green fluorescent protein
International Journal of Molecular Sciences, Vol. 22, Núm. 20
-
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an “HHT-like” syndrome in children
Molecular Genetics and Genomic Medicine, Vol. 9, Núm. 12
2020
-
Differential expression of circulating plasma mirna-370 and mirna-10a from patients with hereditary hemorrhagic telangiectasia
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14
-
Electrochemically reduced graphene oxide on CoCr biomedical alloy: Characterization, macrophage biocompatibility and hemocompatibility in rats with graphene and graphene oxide
Materials Science and Engineering C, Vol. 109
2019
-
Characterization of a family mutation in the 5’ untranslated region of the endoglin gene causative of hereditary hemorrhagic telangiectasia
Journal of Human Genetics, Vol. 64, Núm. 4, pp. 333-339
-
Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners
Cells, Vol. 8, Núm. 9
2018
2017
-
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia
Expert Opinion on Therapeutic Targets, Vol. 21, Núm. 10, pp. 933-947
2016
-
Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities
Cancer Cell International, Vol. 16, Núm. 1
2015
-
Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4
Annals of Hematology, Vol. 94, Núm. 3, pp. 379-392
2014
-
Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activities
PLoS ONE, Vol. 9, Núm. 12
-
Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: Energy depletion, oxidative stress, and protein kinase activity modulations
Journal of Pharmacology and Experimental Therapeutics, Vol. 348, Núm. 2, pp. 324-335
2012
-
2-Deoxy-d-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: Involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways
Biochemical Pharmacology, Vol. 84, Núm. 12, pp. 1604-1616
-
Raf/MEK/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562
Experimental Biology and Medicine, Vol. 237, Núm. 8, pp. 933-942
2011
-
Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation
Biochemical Pharmacology, Vol. 82, Núm. 11, pp. 1619-1629